1. Zahoor, Insha, Haq, Ehtishamul, Asimi, Ravouf. . Multiple Sclerosis and EIF2B5: A Paradox or a Missing Link. In Advances in experimental medicine and biology, 958, 57-64. doi:10.1007/978-3-319-47861-6_5. https://pubmed.ncbi.nlm.nih.gov/28093708/
2. Terumitsu-Tsujita, Mika, Kitaura, Hiroki, Miura, Ikuo, Takebayashi, Hirohide, Igarashi, Hironaka. 2019. Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model. In Journal of neurochemistry, 154, 25-40. doi:10.1111/jnc.14887. https://pubmed.ncbi.nlm.nih.gov/31587290/
3. Böck, Desirée, Revers, Ilma M, Bomhof, Anastasia S J, van Til, Niek P, Schwank, Gerald. 2024. In vivo base editing of a pathogenic Eif2b5 variant improves vanishing white matter phenotypes in mice. In Molecular therapy : the journal of the American Society of Gene Therapy, 32, 1328-1343. doi:10.1016/j.ymthe.2024.03.009. https://pubmed.ncbi.nlm.nih.gov/38454603/
4. Kong, Fanxin, Zheng, Haotao, Liu, Xuan, Wang, Jianjun, Guo, Zhouke. 2022. Association Between Late-Onset Leukoencephalopathy With Vanishing White Matter and Compound Heterozygous EIF2B5 Gene Mutations: A Case Report and Review of the Literature. In Frontiers in neurology, 13, 813032. doi:10.3389/fneur.2022.813032. https://pubmed.ncbi.nlm.nih.gov/35785335/
5. Herstine, Jessica A, Chang, Pi-Kai, Chornyy, Sergiy, Bonkowsky, Joshua L, Bradbury, Allison M. 2024. Evaluation of safety and early efficacy of AAV gene therapy in mouse models of vanishing white matter disease. In Molecular therapy : the journal of the American Society of Gene Therapy, 32, 1701-1720. doi:10.1016/j.ymthe.2024.03.034. https://pubmed.ncbi.nlm.nih.gov/38549375/
6. Mathis, Stéphane, Scheper, Gert C, Baumann, Nicole, van der Knaap, Marjo S, Neau, Jean-Philippe. 2008. The ovarioleukodystrophy. In Clinical neurology and neurosurgery, 110, 1035-7. doi:10.1016/j.clineuro.2008.06.002. https://pubmed.ncbi.nlm.nih.gov/18678442/
7. Hou, Lin, Jiao, Yan, Li, Yanqing, Yang, Zhaoying, He, Miao. . Low EIF2B5 expression predicts poor prognosis in ovarian cancer. In Medicine, 99, e18666. doi:10.1097/MD.0000000000018666. https://pubmed.ncbi.nlm.nih.gov/32000373/